FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AMA President-Elect Confronts a New Challenge: A Brain Tumor

2.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

3.

On all CAR-T products, the FDA is calling for a new boxed warning.

4.

examining differences in the rates of breast reconstruction following mastectomies.

5.

We Don't Always Know What's 'Best' for Our Patients


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot